Biotech startups that raised Series C in Guangdong, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Shengqiang Technology | Shenzhen | Series C | $13.7M | 2026-07-26 |
| Tianchen Biotechnology | Tianjin | Series C | $27.8M | 2025-06-03 |
| Shanhai Innovation | Shenzhen | Series C | $13.7M | 2025-04-16 |
| Zhiyi Pharmaceutics | Guangzhou | Series C | $13.8M | 2024-03-28 |
| Canton Biologics | Guangzhou | Series C | $41.3M | 2023-09-13 |
5 rows of the CSV in 5 of its 18 columns.
- The 29 biotech startups in Guangdong, China whose last round is Series C have raised $662.1M in total.
- 4 of them closed their most recent round in the last 12 months, $64.7M combined.
- The largest of those rounds is Conmind Medical's $29.1M Series C, dated April 2026.
- The most recent is Realmind Biotech's $7.4M Series C on 20 August 2026.
- SDIC Venture Capital is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 25 companies (86%).
- 3% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 51 to 100 employees (39% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 29| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Shengqiang Technology | Shengqiang Technology researches, manufactures, and sells high-tech products. | Biotech | Shenzhen | Series C | $13.7M | 2026-07-26 | $13.7M | SDIC Venture Capital | 101 to 250 | 2013 |
| Tianchen Biotechnology | Tianchen Biotechnology develops and sells medical products for ophthalmology. | Biotech | Tianjin | Series C | $27.8M | 2025-06-03 | $41.7M | CMB International Capital Corporation | 2018 | |
| Zhiyi Pharmaceutics | Zhiyi Pharmaceutics researches and develops second-generation probiotics and live biotherapeutics. | Biotech | Guangzhou | Series C | $13.8M | 2024-03-28 | Shenzhen Capital Group, SDIC Venture Capital, Sinoking Capital | 51 to 100 | 2013 | |
| Canton Biologics | Canton Biologics provides biologics contract development and manufacturing outsourcing services. | Biotech | Guangzhou | Series C | $41.3M | 2023-09-13 | $41.7M | SDIC Venture Capital, Rongtuo Capital Management, Taipu Life Sciences Investment | 101 to 250 | 2016 |
Table 1. Biotech startups that raised Series C in Guangdong, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 29.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Shengqiang Technology | Shengqiang Technology researches, manufactures, and sells high-tech products. | Biotech | Shenzhen | Series C | $13.7M | 2026-07-26 | $13.7M | SDIC Venture Capital | 101 to 250 | 2013 |
Table 2. Biotech startups that raised Series C in Guangdong, China: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | SDIC Venture Capital | Venture capital firm | Xicheng, China | 3 | 10% | 1 | Shengqiang Technology |
| 2 | Shenzhen Guozhong Venture Capital Management | Venture capital firm | Shenzhen, China | 2 | 7% | ||
| 3 | CMB International Capital Corporation | Investment bank | Central, Hong Kong | 1 | 3% | ||
| 4 | Hongtai Capital Holdings | Private equity firm | Beijing, China | 1 | 3% | ||
| 5 | Hongtai Fund | Private equity firm | Shenzhen, China | 1 | 3% | ||
| 6 | Cowin Capital | Private equity firm | Shenzhen, China | 1 | 3% | ||
| 7 | Oriental Fortune Capital | Venture capital firm | Shenzhen, China | 1 | 3% | ||
| 8 | Amphora Capital | Venture capital firm | Beijing, China | 1 | 3% | ||
| 9 | Dong Fang Rong Run | Private equity firm | Shenzhen, China | 1 | 3% | ||
| 10 | BOC & Utrust Private Equity Fund Management | Private equity firm | Guangzhou, China | 1 | 3% | ||
| 11 | Sinoking Capital | Venture capital firm | Beijing, China | 1 | 3% | ||
| 12 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 1 | 3% | ||
| 13 | CEC Capital | Hedge fund | Beijing, China | 1 | 3% | ||
| 14 | GAINS Investment Corp. | Private equity firm | Kaohsiung, Taiwan | 1 | 3% | ||
| 15 | Taipu Life Sciences Investment | 1 | 3% |
Table 3. Biotech startups that raised Series C in Guangdong, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 25 | 86% | $606.7M |
| Hardware | 1 | 3% | |
| Cybersecurity | 1 | 3% |
Table 4. Biotech startups that raised Series C in Guangdong, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 29 | 100% | $14.5M |
Table 5. Biotech startups that raised Series C in Guangdong, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Guangzhou | 12 | 41% |
| Shenzhen | 10 | 34% |
| Tianjin | 3 | 10% |
| Zhuhai | 1 | 3% |
| Huangpu | 1 | 3% |
| Nansha | 1 | 3% |
| Longhua | 1 | 3% |
Table 6. Biotech startups that raised Series C in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| August 2026 | 1 | 25% | $7.4M |
| July 2026 | 1 | 25% | $13.7M |
| April 2026 | 1 | 25% | $29.1M |
| March 2026 | 1 | 25% | $14.5M |
Table 7. Biotech startups that raised Series C in Guangdong, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 14% | $64.7M |
| 2025 | 4 | 14% | $110.5M |
| 2024 | 3 | 10% | $55.1M |
| 2023 | 6 | 21% | $176.3M |
| 2022 | 3 | 10% | $53.6M |
| 2021 | 4 | 14% | $104.1M |
Table 8. Biotech startups that raised Series C in Guangdong, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 1 | 3% |
| 2015 to 2019 | 16 | 55% |
| 2010 to 2014 | 6 | 21% |
| Before 2010 | 6 | 21% |
Table 9. Biotech startups that raised Series C in Guangdong, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 3 | 13% |
| 11 to 50 | 2 | 9% |
| 51 to 100 | 9 | 39% |
| 101 to 250 | 5 | 22% |
| 251 to 500 | 3 | 13% |
| 501 to 1,000 | 1 | 4% |
Table 10. Biotech startups that raised Series C in Guangdong, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series C and its headquarters is in Guangdong, China. On 16 November 2026 that is 29 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 29 rows: 7 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Guangdong, China whose last round is Series C are on the list?
- 29, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 29 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.